Sex Reassignment Surgery Market - Top Companies and Manufacturers

Companies Dominating the Sex Reassignment Surgery Landscape

The industry's leading service providers are always updating their technologies to maintain an edge over rivals and to guarantee dependability, effectiveness, and security. In order to obtain a competitive edge over their rivals and seize a substantial portion of the market, these firms concentrate on collaboration, product improvements, and partnerships.

Bupa Group
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Mayo Clinic
Amish Hospital
Boston Medical Center
Cleveland Clinic
Transgender Surgery Institute
Plastic Surgery Group of Rochester
The Johns Hopkins University
IM Gender Clinic
GRS Montreal Clinic

Browse Key Market Insights with Data Illustration:

Sex Reassignment Surgery Market Size | Growth Trends 2037

In the News

Bupa UK Insurance has announced a suite of new offerings for its UK business customers under the brand name Inclusive Health. The new offerings supplement Bupa's already comprehensive portfolio of inclusive health benefits. Bupa presently provides a best-in-class gender dysphoria proposition that includes comprehensive assistance for employees during their transition, including gender reaffirmation surgery.
Mayo Clinic Urogynecology and Radiology anatomic modeling, in collaboration with colleagues from three other institutions, developed a 3D-printed, anatomically customizable vaginal mold for use postoperatively after vaginoplasty. These findings were published in the journal Obstetrics & Gynecology in August 2022. Given the favorable outcome of the case presented in this journal, as well as the increasing availability of 3D printing, the study authors believe customized, 3D-printed vaginal molds hold potential for tailored vaginal agenesis treatment.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of sex reassignment surgery is estimated at USD 876.47 million.

The sex reassignment surgery market size was over USD 802.04 million in 2024 and is anticipated to cross USD 3.34 billion by 2037, witnessing more than 11.6% CAGR during the forecast period i.e., between 2025-2037. The market growth is impelled by surge in the prevalence of gender dysphoria.

Europe industry is likely to account for largest revenue share of 35% by 2037, influenced by rise in disposable income, which can inspire people with gender dysphoria to invest in gender change surgeries in the region.

The major players in the market are Bupa Group, Mayo Clinic, Amish Hospital, Boston Medical Center, Cleveland Clinic, Transgender Surgery Institute, Plastic Surgery Group of Rochester, The Johns Hopkins University, IM Gender Clinic, GRS Montreal Clinic, and others.

Sex Reassignment Surgery Market - Top Companies and Manufacturers

Companies Dominating the Sex Reassignment Surgery Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What is the size of the sex reassignment surgery market?

Why is the sex reassignment surgery sector gaining traction in near future?

Which region accounted for the largest sex reassignment surgery industry share?

Who are the major sex reassignment surgery players?